CORDIS · 295010 · FP7
KHCCBIO Supporting the Establishment of a Cancer Biobank for Jordan and its Neighbouring Countries Through Knowledge Transfer & Training
Coordinator: KING HUSSEIN CANCER FOUNDATION (JO)
The King Hussein Cancer Center (KHCC) in Jordan, a highly accredited hospital, treats over 3,500 new adult and paediatric cancer patients annually from Jordan and its neighbouring countries. KHCC wishes to maintain its pioneering position in cancer detection and treatment and plans to establish a state-of-the-art biospecimen repository to store and archive tissue samples for use in cancer research with the support and experience of experts in biobanking and quality management from Trinity College Dublin and two European SMEs.The KHCCBIO bank will collect, process, extract, store high-quality,…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
The project runs over approximately 2.5 years from 2011-11-15 to 2014-05-14.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from JO
see all →- EU-JORDANNET II — Enhancement of Jordan-European S&T Partnerships311910 · FP7 · €683k
- JORIEW — Improving capacity of Jordanian Research in Integrated Renewable Energy and Water supply266579 · FP7 · €499k
- EU-JORDANNET — Enhancement of Jordan-European S&T Partnerships244082 · FP7 · €499k
- JEWEL — Jordan Europe Wide Enhanced research Links in ICT266507 · FP7 · €499k
- IJERA — Integrating Jordan into the European Research Area266514 · FP7 · €499k
- BOT-ERA — Reinforcing cooperation between the Royal Botanic Garden of Jordan and ERA294416 · FP7 · €498k
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CSA-SA funding scheme.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by KING HUSSEIN CANCER FOUNDATION (JO).
- What is the project timeline?
- The project runs from 2011-11-15 to 2014-05-14 — approximately 2.5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 295010.